tiprankstipranks
Knight Therapeutics (KHTRF)
OTHER OTC:KHTRF

Knight Therapeutics (KHTRF) Financial Statements

31 Followers

Knight Therapeutics Financial Overview

Knight Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.129; its P/E ratio is -32.18; Knight Therapeutics is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $0.02. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total RevenueC$ 86.60MC$ 74.20MC$ 81.50MC$ 89.91MC$ 82.60M
Gross ProfitC$ 41.70MC$ 34.22MC$ 40.18MC$ 37.49MC$ 40.76M
EBITC$ -4.57MC$ -22.06MC$ 11.50MC$ 3.22MC$ -2.15M
EBITDAC$ 8.01MC$ -10.60MC$ 25.20MC$ 15.37MC$ 10.93M
Net Income Common StockholdersC$ -4.55MC$ -24.33MC$ 9.59MC$ 1.84MC$ -3.94M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 174.27MC$ 154.42MC$ 142.46MC$ 130.50MC$ 145.31M
Total AssetsC$ 968.21MC$ 945.49MC$ 1.01BC$ 1.01BC$ 1.04B
Total DebtC$ 70.09MC$ 69.09MC$ 82.24MC$ 79.20MC$ 82.64M
Net DebtC$ -104.18MC$ -85.33MC$ -60.22MC$ -51.30MC$ -62.67M
Total LiabilitiesC$ 206.32MC$ 198.62MC$ 196.48MC$ 206.54MC$ 225.91M
Stockholders EquityC$ 761.89MC$ 746.87MC$ 814.66MC$ 807.20MC$ 818.87M
Cash Flow-
Free Cash FlowC$ 19.95MC$ 18.75MC$ 14.88MC$ -1.64MC$ -4.08M
Operating Cash FlowC$ 30.88MC$ 18.55MC$ 15.17MC$ -1.49MC$ 3.71M
Investing Cash FlowC$ -24.37MC$ -1.90MC$ 35.76MC$ 4.20MC$ -8.71M
Financing Cash FlowC$ -2.90MC$ -36.40MC$ -11.24MC$ -22.09MC$ -11.27M
Currency in CAD

Knight Therapeutics Earnings and Revenue History

Knight Therapeutics Debt to Assets

Knight Therapeutics Cash Flow

Knight Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis